Kausik K Ray

Summary

Affiliation: University of Cambridge
Country: UK

Publications

  1. ncbi Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
    Kausik K Ray
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
    Lancet 373:1765-72. 2009
  2. ncbi Leukocyte telomere length is associated with high-risk plaques on virtual histology intravascular ultrasound and increased proinflammatory activity
    Patrick A Calvert
    Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK
    Arterioscler Thromb Vasc Biol 31:2157-64. 2011
  3. ncbi Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants
    Kausik K Ray
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, England
    Arch Intern Med 170:1024-31. 2010
  4. ncbi Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe?
    Sreenivasa R K Seshasai
    Molecular Epidemiology Unit, Strangeways Research Laboratory, Worts Causeway, Cambridge, CB1 8RN, UK
    Future Cardiol 5:129-39. 2009
  5. ncbi Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes
    Kausik K Ray
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
    J Thromb Thrombolysis 30:10-3. 2010
  6. ncbi B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies
    Emanuele Di Angelantonio
    Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Wort s Causeway, Cambridge, England CB1 8RN
    Circulation 120:2177-87. 2009
  7. ncbi Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study
    Patrick A Calvert
    Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom
    JACC Cardiovasc Imaging 4:894-901. 2011
  8. ncbi Biomarkers, C-reactive proteins and statins in acute coronary syndromes
    Kausik K Ray
    Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK
    Fundam Clin Pharmacol 21:31-3. 2007
  9. ncbi Intensive statin therapy in acute coronary syndromes
    Tze Vun Liew
    Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, CB1 8RN, UK
    Curr Atheroscler Rep 10:158-63. 2008
  10. ncbi Aggressive statin therapy for acute coronary syndromes
    Tze Vun Liew
    Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge CB1 8RN, UK
    Curr Cardiol Rep 9:298-302. 2007

Collaborators

Detail Information

Publications12

  1. ncbi Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
    Kausik K Ray
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
    Lancet 373:1765-72. 2009
    ..We undertook a meta-analysis of randomised controlled trials to determine whether intensive treatment is beneficial...
  2. ncbi Leukocyte telomere length is associated with high-risk plaques on virtual histology intravascular ultrasound and increased proinflammatory activity
    Patrick A Calvert
    Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK
    Arterioscler Thromb Vasc Biol 31:2157-64. 2011
    ..However, whether LTL reflects plaque extent or unstable plaques, and the mechanisms underlying any association are unknown...
  3. ncbi Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants
    Kausik K Ray
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, England
    Arch Intern Med 170:1024-31. 2010
    ..Our objective was to reliably determine if statin therapy reduces all-cause mortality among intermediate to high-risk individuals without a history of CVD...
  4. ncbi Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe?
    Sreenivasa R K Seshasai
    Molecular Epidemiology Unit, Strangeways Research Laboratory, Worts Causeway, Cambridge, CB1 8RN, UK
    Future Cardiol 5:129-39. 2009
    ..The aim of this narrative article is to provide a critical and up-to-date summary of the findings of clinical trials of intensive statin therapy, including a brief overview of the safety and efficacy of such treatments...
  5. ncbi Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes
    Kausik K Ray
    Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
    J Thromb Thrombolysis 30:10-3. 2010
    ..0028). These analyses suggest that although PCI may acutely increase inflammation, it may also serve a role in decreasing inflammation associated with atherosclerotic plaques via long-term mechanical stabilization...
  6. ncbi B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies
    Emanuele Di Angelantonio
    Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Wort s Causeway, Cambridge, England CB1 8RN
    Circulation 120:2177-87. 2009
    ....
  7. ncbi Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study
    Patrick A Calvert
    Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom
    JACC Cardiovasc Imaging 4:894-901. 2011
    ....
  8. ncbi Biomarkers, C-reactive proteins and statins in acute coronary syndromes
    Kausik K Ray
    Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK
    Fundam Clin Pharmacol 21:31-3. 2007
    ..Further understanding the role of different biomarkers will help better understand the pathophysiology of ACS as well as provide personalized medical care...
  9. ncbi Intensive statin therapy in acute coronary syndromes
    Tze Vun Liew
    Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, CB1 8RN, UK
    Curr Atheroscler Rep 10:158-63. 2008
    ..This paper examines the evidence for statin use in ACS...
  10. ncbi Aggressive statin therapy for acute coronary syndromes
    Tze Vun Liew
    Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge CB1 8RN, UK
    Curr Cardiol Rep 9:298-302. 2007
    ..This article examines this emerging evidence for the use of statins in ACS...
  11. ncbi Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
    Kausik K Ray
    Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom
    Am J Cardiol 98:18P-25P. 2006
    ..This article reviews some of the key statin trials in ACS and assesses the evidence for benefits of these drugs independent of their effects on LDL cholesterol...
  12. ncbi Intensive statin therapy for treating acute coronary syndromes
    Kausik K Ray
    University of Cambridge, Department of Public Health and Primary Care, Strangeways Research Laboratory, Addenbrookes Hospital, Cambridge, CB1 8RN, UK
    Expert Opin Investig Drugs 15:1151-9. 2006
    ..This paper reviews the current state of evidence from the key statin trials in ACS and their implications for the future management of ACS...